Tevogen Inc. (TVGN)
TVGN moved a median of -0.19% 30 minutes after news, and -0.40% by the close. How TVGN actually reacts to news — the realized, point-in-time move the market made, measured across 307 labeled events over the last three years with zero look-ahead.
TVGN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 44% | 276 |
| 30-min | -0.19% | 42% | 295 |
| 60-min | -0.45% | 38% | 298 |
| to close | -0.40% | 44% | 301 |
| Middle 50% of TVGN reactions | -1.77% to +1.20% |
|---|---|
| Median reaction (30-min) | -0.19% |
| Measured reactions | 307 |
Half of all Tevogen Inc. news events land between -1.77% and +1.20% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when TVGN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TVGN's baseline. Nothing else.
Recent TVGN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC | Press release | GlobeNewswire | -9.41% | +0.71% | |
| UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC | Press release | GlobeNewswire | -2.13% | +0.14% | |
| Form 8-K Tevogen Inc. For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | +2.83% | +5.83% | |
| Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements | Press release | GlobeNewswire | +2.83% | +5.83% | |
| Form 8-K Tevogen Inc. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | +3.14% | +8.59% | |
| Form 8-K Tevogen Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | — | +0.69% | |
| Form 8-K Tevogen Inc. For: Aug 24 | SEC filing · Form 8-K | SEC EDGAR | — | -1.32% | |
| Form S-8 Tevogen Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | +5.29% | |
| Form 10-Q Tevogen Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -1.20% | |
| Form DEF 14A Tevogen Inc. For: Aug 03 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -2.90% | |
| Form 8-K Tevogen Bio Holdings For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +9.80% | |
| Tevogen Bio Holdings Inc. Becomes Tevogen Inc. | Press release | GlobeNewswire | -5.19% | +6.26% | |
| Form PRE 14A Tevogen Bio Holdings For: Jul 23 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +7.16% | |
| Tevogen Bio Announces 2026 Annual Meeting of Stockholders | Press release | GlobeNewswire | — | -0.20% | |
| Form S-8 Tevogen Bio Holdings | SEC filing · Form S-8 | SEC EDGAR | — | -0.40% | |
| Form EFFECT Tevogen Bio Holdings | SEC filing · Form EFFECT | SEC EDGAR | +3.48% | -26.24% | |
| Form S-3 Tevogen Bio Holdings | SEC filing · Form S-3 | SEC EDGAR | +0.00% | -3.84% | |
| Tevogen Announces Formation of a Healthcare Services Initiative | Press release | GlobeNewswire | — | -2.71% | |
| Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue | Press release | GlobeNewswire | +8.75% | -4.96% | |
| Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization | Press release | GlobeNewswire | — | +8.69% | |
| Letter to Shareholders from CEO Dr. Ryan Saadi | Press release | GlobeNewswire | — | +11.28% | |
| Form 10-Q Tevogen Bio Holdings For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +8.29% | |
| Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close | Press release | GlobeNewswire | +13.80% | -6.69% | |
| Form 10-K/A Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.38% | -3.06% | |
| Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | Press release | GlobeNewswire | -4.79% | -5.47% | |
| Form 8-K Tevogen Bio Holdings For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | — | -13.35% | |
| Form 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +2.69% | +0.45% | |
| Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth | Press release | GlobeNewswire | +0.48% | -6.31% | |
| Form 8-K Tevogen Bio Holdings For: Mar 20 | SEC filing · Form 8-K | SEC EDGAR | +1.52% | -9.33% | |
| Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement | Press release | GlobeNewswire | +1.55% | +0.58% | |
| Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) | Press release | GlobeNewswire | — | +5.86% | |
| Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization | Press release | GlobeNewswire | — | -3.06% | |
| Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure | Press release | GlobeNewswire | +8.44% | -15.14% | |
| Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform | Press release | GlobeNewswire | +0.48% | +2.96% | |
| Tevogen Names Leadership Team to Execute Diversified Growth Strategy | Press release | GlobeNewswire | +1.90% | +13.30% | |
| Letter to Shareholders from CEO Dr. Ryan Saadi | Press release | GlobeNewswire | — | +4.28% | |
| Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical | Press release | GlobeNewswire | +0.38% | -2.82% | |
| Form 8-K Tevogen Bio Holdings For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | -2.12% | -1.43% | |
| Tevogen Announces Reverse Stock Split | Press release | GlobeNewswire | -2.12% | -1.43% | |
| Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization | Press release | GlobeNewswire | — | -1.64% | |
| Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus | Press release | GlobeNewswire | +0.86% | -0.21% | |
| UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus | Press release | GlobeNewswire | +0.00% | -5.64% | |
| Form 8-K Tevogen Bio Holdings For: Feb 19 | SEC filing · Form 8-K | SEC EDGAR | +0.86% | -0.21% | |
| Form 8-K Tevogen Bio Holdings For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | -1.54% | -4.32% | |
| Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders | Press release | GlobeNewswire | — | -4.65% | |
| Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue | Press release | GlobeNewswire | +1.47% | +0.69% | |
| Form DEF 14A Tevogen Bio Holdings For: Jan 26 | SEC filing · Form DEF | SEC EDGAR | -0.12% | +2.35% | |
| Form PRE 14A Tevogen Bio Holdings For: Dec 31 | SEC filing · Form PRE | SEC EDGAR | -2.22% | -6.99% | |
| Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 | Press release | GlobeNewswire | -0.78% | -15.80% | |
| Tevogen CEO Donates Shares to Support Education for Underprivileged Children | Press release | GlobeNewswire | +0.00% | +1.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TVGN section they belong to.
Where else TVGN is measured.
TVGN earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Tevogen Inc.'s median reaction calculated?
Every labeled TVGN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 307 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 42% of TVGN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TVGN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.